Predictors of Endoscopic Response and Remission in Patients with Active Crohn's Disease Treated with Certolizumab Pegol: A Logistic Regression Analysis of the Music Data

被引：0
|
作者：
Colombel, Jean-Frederic
Lemann, Marc
Allez, Matthieu
Mitchev, Krassimir
Jamoul, Corinne
Hebuterne, Xavier
机构：
来源：
GASTROENTEROLOGY | 2009年 / 136卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A181 / A181
页数：1
相关论文
共 50 条
  • [1] Predictors of response in patients with active Crohn's disease treated with certolizumab pegol: A multiple regression analysis of PRECISE 2 data
    Hanauer, Stephen B.
    Schreiber, Stefan
    Thomsen, Ole O.
    Lichtenstein, Gary R.
    Bloomfield, Ralph
    Sandborn, William J.
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A489 - A490
  • [2] Predictors of Response and Remission to Certolizumab Pegol in Patients With Crohn's Disease: Data From the WELCOME Study
    Sandborn, William J.
    Abreu, Maria T.
    D'Haens, Geert R.
    Colombel, Jean-Frederic
    Vermeire, Severine
    Mitchev, Krassimir
    Ernault, Etienne
    Fedorak, Richard N.
    Spehlmann, Martina
    Wolf, Douglas C.
    Lee, Scott D.
    Rutgeerts, Paul J.
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S164 - S164
  • [3] Endoscopic Mucosal improvement in patients with active Crohn's Disease treated with Certolizumab Pegol: First results of the MUSIC Clinical Trial
    Colombel, J.
    Lemann, M.
    Bouhnik, Y.
    Dewit, O.
    Dupas, J.
    Ross, M.
    D'Haens, G.
    Mitchev, K.
    Vermeire, S.
    Brixi-Benmansour, H.
    Moreels, V
    Hebuterne, X.
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 (12) : S25 - S25
  • [4] Endoscopic mucosal improvement in patients with active Crohn's disease treated with certolizumab pegol:: first results of the music clinical trial
    Colombel, Jean-Frederic
    Hebuterne, Xavier
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S432 - S432
  • [5] Endoscopic Mucosal Improvement in Patients With Active Crohn's Disease Treated With Certolizumab Pegol: Week 10 and 54 Results of the Music Trial
    Colombel, Jean-Frederic
    Lemann, Marc
    Bouhnik, Yoram
    Dewit, Olivier
    Dupas, Jean-Louis
    Mross, Michael R.
    D'Haens, Geert R.
    Mitchev, Krassimir
    Vermeire, Severine
    Brixi-Benmansour, Hedia
    Moreels, Tom G.
    Hebuterne, Xavier
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S166 - S166
  • [6] Certolizumab pegol for induction of remission in Crohn's disease
    Yamazaki, Hajime
    So, Ryuhei
    Matsuoka, Katsuyoshi
    Kobayashi, Taku
    Shinzaki, Shinichiro
    Matsuura, Minoru
    Okabayashi, Shinji
    Kataoka, Yuki
    Tsujimoto, Yasushi
    Furukawa, Toshi A.
    Watanabe, Norio
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (08):
  • [7] Maintenance of response and remission rates after 18 months of treatment with certolizumab pegol in patients with active Crohn's disease
    Lichtenstein, Gary R.
    Schreiber, Stefan
    Sandbom, William J.
    Hanauer, Stephen B.
    Feagan, Brian G.
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A502 - A502
  • [8] Certolizumab Pegol for Active Crohn's Disease Reply
    Sandborn, William J.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (03) : 327 - 328
  • [9] Response to certolizumab pegol induction is not steroid-dependent in patients with active Crohn's disease
    Hommes, Daniel W.
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A494 - A494
  • [10] Fecal Calprotectin Concentration and Clinical Remission in Patients with Active Crohn's Disease Treated with Certolizumab Pegol: Results from PRECiSE 1
    Sandborn, William
    Ullman, Thomas
    Pierre-Louis, Bosny
    Binion, David
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S441 - S441
12345